Atlas Trials

Phase 2 Study of Velusetrag in Diabetic or Idiopathic Gastroparesis

Clinical trial NCT01718938 · COMPLETED

Trial details

NCT number
NCT01718938
Sponsor
Theravance Biopharma
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Gastroparesis
Start date
2012-12-01
Primary completion
2013-12-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.